Medicare Enrolled

Dr. Charles Wykoff, MD, PHD

Retina Specialist (Ophthalmology) Physician · Bellaire, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
4460 BISSONNET ST STE 200, Bellaire, TX 77401
7135243434
In practice since 2007 (18 years)
NPI: 1124237300 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wykoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wykoff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wykoff

Dr. Charles Wykoff is a retina specialist (ophthalmology) physician in Bellaire, TX, with 18 years in practice. Based on federal Medicare data, Dr. Wykoff performed 32,697 Medicare services across 3,820 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wykoff received a total of $1,421,067 from 49 pharmaceutical and/or device companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wykoff is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 7% volume in TX$ $1,421,067 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,697
Medicare services
Top 7% in TX for retina specialist (ophthalmology) physician
3,820
Unique beneficiaries
$191
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,816 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)12,671$29$113
Aflibercept eye injection (Eylea)4,844$688$2,703
Retinal imaging (OCT scan)3,494$29$127
Injection, pegcetacoplan, intravitreal, 1 mg3,135$120$451
Injection, ranibizumab, 0.1 mg2,872$180$774
Eye injection for retinal disease2,609$99$493
Comprehensive eye exam, established patient1,938$89$396
Unclassified drugs419$1,984$7,671
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg207$219$840
Comprehensive eye exam, new patient117$101$469
Unclassified biologics102$1,953$6,981
Office visit, established patient (30-39 min)80$92$400
New patient office visit (45-59 min)68$117$521
Retinal photography (fundus photo)58$28$116
Removal of eye fluid24$121$370
Photocoagulation treatment to prevent detachment of retina20$186$752
Exam of retinal blood vessels using a special camera after injection of a dye16$102$394
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye12$206$788
Eye exam, established patient, focused11$64$280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,421,067
Total received (2018-2024)
Avg $203,010/year across 7 years
Top 1% in TX for retina specialist (ophthalmology) physician
49
Companies
746
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,212,348 (85.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$206,039 (14.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,680 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$394,856
2023
$193,077
2022
$113,172
2021
$142,174
2020
$207,700
2019
$205,010
2018
$165,077

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$182,258
Apellis Pharmaceuticals, Inc.
$152,713
EyePoint Pharmaceuticals US, Inc.
$142,506
Regeneron Pharmaceuticals, Inc.
$122,833
Boehringer Ingelheim International GmbH
$120,354
Novartis Pharma AG
$102,246
F. Hoffmann-La Roche AG
$85,807
Genentech, Inc.
$80,892
Novartis Pharmaceuticals Corporation
$76,602
Janssen Research & Development, LLC
$45,073
ABBVIE INC.
$40,056
Allergan Inc.
$31,406
SANOFI US SERVICES INC.
$26,646
Genentech USA, Inc.
$21,848
Janssen Global Services, LLC
$19,558
Alimera Sciences, Inc.
$18,670
Alcon Vision LLC
$14,225
Takeda Pharmaceuticals U.S.A., Inc.
$13,175
Allergan, Inc.
$12,648
AbbVie Inc.
$11,656
NOVARTIS PHARMACEUTICALS CORPORATION
$10,212
Shire North American Group Inc
$8,574
Merck Sharp & Dohme LLC
$8,176
Merck Sharp & Dohme Corporation
$8,175
Bausch & Lomb, a division of Bausch Health US, LLC
$7,977
Bausch & Lomb Americas Inc.
$7,552
Hexal AG
$7,525
Dutch Ophthalmic, USA
$5,000
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,750
Kowa Research Institute, Inc.
$4,500
BioCryst Pharmaceuticals, Inc.
$4,462
Thrombogenics, Inc.
$3,750
Alnylam Pharmaceuticals Inc.
$3,640
Astellas Pharma US Inc
$3,600
Bayer Healthcare Pharmaceuticals Inc.
$2,520
Alcon Research LLC
$2,051
Janssen Pharmaceuticals, Inc
$1,815
Hoffmann-La Roche Limited
$1,570
NotalVision
$1,125
Aerie Pharmaceuticals, Inc.
$998
Carl Zeiss Meditec, Inc.
$880
Ocular Therapeutix, Inc.
$286
OPTOVUE, INC.
$236
Biogen, Inc.
$174
Coherus Biosciences Inc.
$133
Alcon Laboratories Inc
$96
Spark Therapeutics, Inc.
$82
Horizon Therapeutics plc
$19
Mallinckrodt Enterprises LLC
$16
Top 3 companies account for 33.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · BEOVU · BLZ_BEOVU_OPHTHALMOLOGY · BROLUCIZUMAB · BVU_BEOVU_OPHTHALMOLOGY · BYOOVIZ · CIRRUS HD-OCT · Cimerli · Constellation · DEXTENZA · DUREZOL · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · ForeseeHome · ILUVIEN · Iluvien · Izervay · Jetrea · LUXTURNA · Lucentis · Non-Covered Product · OZURDEX · RTH258A_BEOVU_OPHTHALMOLOGY · STELLARIS · SUSVIMO · SYFOVRE · Syfovre · TAKHZYRO · TEPEZZA · VABYSMO · VEOPOZ · VISUDYNE · VYZULTA · Vabysmo · XIPERE · XR · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for retina specialist (ophthalmology) physician in TX.

Equivalent to $4,346 per 100 Medicare services performed
Looking for a retina specialist (ophthalmology) physician in Bellaire?
Compare retina specialist (ophthalmology) physicians in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse retina specialist (ophthalmology) physicians nearby

Geographic Context

Retina Specialist (Ophthalmology) Physicians within 10 mi
19
Per 100K population
0.4
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wykoff is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (consulting-driven, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wykoff experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Wykoff performed 12,671 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wykoff receive payments from pharmaceutical companies?
Yes. Dr. Wykoff received a total of $1,421,067 from 49 companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wykoff's costs compare to other retina specialist (ophthalmology) physicians in Bellaire?
Dr. Wykoff's average Medicare payment per service is $191. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wykoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →